Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Liabilities and Shareholders Equity: 2021-2024

Historic Liabilities and Shareholders Equity for ProQR Therapeutics N.V (PRQR) over the last 4 years, with Dec 2024 value amounting to $179,479.

  • ProQR Therapeutics N.V's Liabilities and Shareholders Equity rose 23.88% to $145,371 in Q3 2025 from the same period last year, while for Sep 2025 it was $640,096, marking a year-over-year decrease of 99.57%. This contributed to the annual value of $179,479 for FY2024, which is 20.33% up from last year.
  • Per ProQR Therapeutics N.V's latest filing, its Liabilities and Shareholders Equity stood at $179,479 for FY2024, which was up 20.33% from $149,150 recorded in FY2023.
  • ProQR Therapeutics N.V's 5-year Liabilities and Shareholders Equity high stood at $248.0 million for FY2021, and its period low was $149,150 during FY2023.
  • In the last 3 years, ProQR Therapeutics N.V's Liabilities and Shareholders Equity had a median value of $179,479 in 2024 and averaged $58.4 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first plummeted by 99.91% in 2023, then increased by 20.33% in 2024.
  • Yearly analysis of 4 years shows ProQR Therapeutics N.V's Liabilities and Shareholders Equity stood at $248.0 million in 2021, then dropped by 29.52% to $174.8 million in 2022, then tumbled by 99.91% to $149,150 in 2023, then climbed by 20.33% to $179,479 in 2024.